drugset / Trial / NCT01369303
Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of the study is to obtain data on the pharmacokinetics (PK) and pharmacodynamics (PD) and immune system effect of the BAT24 dosing regimen versus daily and pericoital dosing regimens with vaginal use of tenofovir 1% gel after a single sex act and after multiple sex acts.
Timeline
- Start
- 2012-01
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenofovir | Small molecule | 1 % | Other |
Indications
No indication recorded.